新諾威 (300765.SZ)

34.19 +0.18 (+0.53%) 收市：03:04PM CST

新諾威

No. 62 Zhangju Road
Luancheng District
Shijiazhuang 051430
China
86 311 6780 9843
https://www.xnwpharma.net

版塊: Consumer Defensive
行業: Packaged Foods
全職員工: 1,887

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Feng Han	GM & Director	無	無	1974
Mr. Long Dai	Secretary & CFO	無	無	1992

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of functional foods in the field of general health in China and internationally. It offers functional raw materials, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dyphylline, theobromine, pentoxifylline, doxofylline, and biological enzymes; and health food products, such as Guoweikangwei C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.

公司管治

截至 無 止，新諾威 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。